Immunotherapy Special Issue

Understanding how the immune system controls itself has led to advances in immunotherapy.

Patient success stories illustrate the hope promised by cancer immunotherapy.

Rash is the most common side effect of cancer immunotherapies, but patients should watch for more serious issues.

For some with lung cancer, immunotherapies are sparking long-lasting responses.

By empowering the body to fight breast and renal cancers, immunotherapies are poised to improve the treatment landscape.

Clinical development of prostate cancer vaccines is moving forward.

Clinical trials can provide patients with early access to promising cancer immunotherapies.

Within the oncology community, price tags have sparked debate.